Ulcerative colitis: Management in adults, children and young people (NICE Clinical Guideline CG166)

Archives of Disease in Childhood: Education and Practice Edition

Volumn 99, Issue 5, 2014, Pages 194-197

  Stenke, Emily ^a   Hussey, Séamus ^a,b  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS USED IN INFLAMMATORY BOWEL DISEASE; AZATHIOPRINE; BECLOMETASONE DIPROPIONATE; CYCLOSPORIN A; INFLIXIMAB; MERCAPTOPURINE; PREDNISOLONE; STEROID; TACROLIMUS;

ADULT; CLINICAL EVALUATION; CLINICAL PRACTICE; HUMAN; LIMB SALVAGE; MAINTENANCE THERAPY; MANAGED CARE; MEDICAL INFORMATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS; ADOLESCENT; AGED; CHILD; COLITIS, ULCERATIVE; FEMALE; INFANT; MALE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; UNITED KINGDOM; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; FEMALE; GREAT BRITAIN; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; YOUNG ADULT;

EID: 84899779839     PISSN: 17430585     EISSN: 17430593     Source Type: Journal    
DOI: 10.1136/archdischild-2013-305512     Document Type: Review

References (18)

1. Bate J, Gibson F, Johnson E, et al. Ulcerative colitis: Management in adults, children and young people. National Institute for Health and Clinical Excellence, 2013.
2. Van Limbergen J, Russell RK, Drummond HE, et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 2008;135:1114-22.
3. Sandhu BK, Fell JM, Beattie RM, et al. Guidelines for the management of inflammatory bowel disease in children in the United Kingdom. J Ped Gastro Nutr 2010;50(Suppl 1):S1-13.
4. Turner D, Levine A, Escher J, et al. Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J Ped Gastro Nutr 2012;55:340-61.
5. Markowitz J, Grancher K, Rosa J, et al. Growth failure in pediatric inflammatory bowel disease. J Ped Gastro Nutr 1993;16:373-80.
6. Turunen P, Ashorn M, Auvinen A, et al. Long-term health outcomes in pediatric inflammatory bowel disease: a population-based study. Inflamm Bowel Dis 2009;15:56-62.
7. Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology 2007;133:423-43.
8. Turner D, Travis SPL, Griffiths AM, et al. Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN. Am J Gastroenterol 2011;106:578-88.
9. Laharie D, Bourreille A, Branche J, et al. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet 2012;380:1909-15.
10. Turner D, Mack D, Leleiko N, et al. Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response. Gastroenterology 2010;138:2282-91.
11. Hyams J, Damaraju L, Blank M, et al. Induction and Maintenance Therapy With Infliximab for Children With Moderate to Severe Ulcerative Colitis. Clin Gastroenterol Hepatol 2012;10:391-9.
12. Mamula P, Markowitz JE, Cohen LJ, et al. Infliximab in pediatric ulcerative colitis: two-year follow-up. J Pediatr Gastroenterol Nutr 2004;38:298-301.
13. Kunde S, Pham A, Bonczyk S, et al. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J Ped Gastro Nutr 2013;56:597-601.
14. Nylund CM, Goudie A, Garza JM, et al. Venous thrombotic events in hospitalized children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2013;56:485-91.
15. Zitomersky NL, Levine AE, Atkinson BJ, et al. Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2013;57:343-7.
16. Nguyen GC, Bernstein CN, Bitton A, et al. Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology. Gastroenterology 2014;146:835-48.
17. The IBD Standards Group. Standards for the Healthcare of People who have Inflammatory Bowel Disease (IBD). IBD standards. 2013(1-32).
18. Turner D, Hyams J, Markowitz J, et al. Appraisal of the Pediatric Ulcerative Colitis Activity Index (PUCAI). Inflamm Bowel Dis 2009;15:1218-23.